Adoptive immunotherapy of renal cell carcinoma: studies from the Surgery Branch, National Cancer Institute.
Linehan
W M
WM
Surgery Branch, National Cancer Institute, Bethesda, MD 20892.
Walther
M M
MM
Alexander
R B
RB
Rosenberg
S A
SA
D000818:Animals; D002292:Carcinoma, Renal Cell / Q000556:secondary / Q000628:therapy*; D006801:Humans; D016219:Immunotherapy, Adoptive; D016898:Interferon-alpha / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000473:pathology / Q000628:therapy*; D015979:Killer Cells, Lymphokine-Activated; D016246:Lymphocytes, Tumor-Infiltrating; D051379:Mice; D009316:National Institutes of Health (U.S.); D016032:Randomized Controlled Trials as Topic; D014481:United States
D016898:Interferon-alpha; D007376:Interleukin-2